This inventor holds 2 USPTO granted patents. Top assignees: Astellas Pharma Gmbh, National Institute of Advanced Industrial Science and Technology. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2006)
- Tokyo, JP (2010)
Company Filing History:
2 out of 424 
1 out of 1,766 
Years Active: 2006-2010
Title: Kenichi Suzumura: Innovator in Pharmaceutical Research
Introduction
Kenichi Suzumura is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for various medical conditions. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves a 17βHSD type 5 inhibitor. This invention provides a novel and excellent method for treating and/or preventing prostatic cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breast cancer, lung cancer, endometriosis, leiomyoma, and similar conditions. The invention is based on selective inhibitory activity against 17βHSD type 5. It was discovered that an N-sulfonylindole derivative, where the indole ring is substituted by a carboxy group, a carboxy-substituted lower alkyl group, or a carboxy-substituted lower alkenyl group at its carbon atom, exhibits potent selective inhibitory activity against 17βHSD type 5. This compound may serve as a therapeutic and/or preventive agent for benign prostatic hyperplasia and prostatic cancer without causing adverse drug reactions due to a decrease in testosterone.
Another significant patent involves thiopeptide compounds. In this case, a microorganism belonging to a specific genus is cultured, and thiopeptide compounds QN3323 and thiocillin I/II are collected from the culture medium. These compounds are valuable as drugs to treat infections caused by multidrug-resistant bacteria.
Career Highlights
Kenichi Suzumura has worked with prominent organizations in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and the National Institute of Advanced Industrial Science and Technology. His work in these institutions has allowed him to contribute to groundbreaking research and development in the field.
Collaborations
Throughout his career, Kenichi has collaborated with esteemed colleagues, including Tatsuya Niimi and Akio Kamikawa. These collaborations have further enhanced his research capabilities and have led to significant advancements in his field.
Conclusion
Kenichi
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile